The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Authors:
Open Access
- 30 January 2021
- journal article
- review article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2021, 1-9
Abstract
Purpose. Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. Methods. PubMed, Embase, Cochrane Library, CNKI, and Wanfang databases were searched up to May 2020, to identify randomized controlled trials of the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. The Cochrane risk of bias tool was applied to assess the risk of bias, and RevMan5.3 software was used for statistical analysis. Results. Ten studies were included in this study, including 543 subjects. The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD = –11.32, 95% CI = [–14.51, –8.41], ), low-density lipoprotein cholesterol level (WMD = –4.83, 95% CI = [–7.52, –2.14], ), and triglyceride level (WMD = –8.23, 95% CI = [–13.08, –3.38], , but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD = –0.32, 95%CI = [–1.24, 0.60], ). Conclusion. Vitamin D supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol, and triglycerides in patients with polycystic ovary syndrome. However, it has no significant effect on high-density lipoprotein cholesterol.Keywords
This publication has 36 references indexed in Scilit:
- Epidemiology, diagnosis, and management of polycystic ovary syndromeClinical Epidemiology, 2013
- Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysisHuman Reproduction Update, 2013
- Dyslipidemia and Oxidative Stress in PCOS2012
- Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is alteredGynecological Endocrinology, 2011
- Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markersThe American Journal of Clinical Nutrition, 2009
- Pathophysiology and types of dyslipidemia in PCOSTrends in Endocrinology & Metabolism, 2007
- Vitamin D physiologyProgress in Biophysics and Molecular Biology, 2006
- Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003